Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Share-based Compensation (2017 - 2020)

enVVeno Medical has reported Share-based Compensation over the past 4 years, most recently at $518186.0 for Q4 2020.

  • Quarterly results put Share-based Compensation at $518186.0 for Q4 2020, up 163.45% from a year ago — trailing twelve months through Dec 2020 was $881214.0 (up 60.88% YoY), and the annual figure for FY2025 was $3.4 million, down 17.41%.
  • Share-based Compensation for Q4 2020 was $518186.0 at enVVeno Medical, up from $194421.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for NVNO hit a ceiling of $518186.0 in Q4 2020 and a floor of $37717.0 in Q2 2020.
  • Median Share-based Compensation over the past 4 years was $141059.0 (2018), compared with a mean of $183651.7.
  • Biggest five-year swings in Share-based Compensation: plummeted 71.15% in 2018 and later surged 163.45% in 2020.
  • enVVeno Medical's Share-based Compensation stood at $154296.0 in 2017, then surged by 78.65% to $275648.0 in 2018, then decreased by 28.64% to $196695.0 in 2019, then surged by 163.45% to $518186.0 in 2020.
  • The last three reported values for Share-based Compensation were $518186.0 (Q4 2020), $194421.0 (Q3 2020), and $37717.0 (Q2 2020) per Business Quant data.